- Home
- FDUS vs QURE Comparison
FDUS vs QURE Comparison
Compare FDUS & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDUS
- QURE
- Stock Information
- Founded
- FDUS 2011
- QURE 1998
- Country
- FDUS United States
- QURE Netherlands
- Employees
- FDUS N/A
- QURE N/A
- Industry
- FDUS Finance/Investors Services
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- FDUS Finance
- QURE Health Care
- Exchange
- FDUS Nasdaq
- QURE Nasdaq
- Market Cap
- FDUS 654.0M
- QURE 725.4M
- IPO Year
- FDUS 2011
- QURE 2007
- Fundamental
- Price
- FDUS $21.22
- QURE $14.62
- Analyst Decision
- FDUS Hold
- QURE Strong Buy
- Analyst Count
- FDUS 1
- QURE 10
- Target Price
- FDUS $20.00
- QURE $37.20
- AVG Volume (30 Days)
- FDUS 199.8K
- QURE 1.1M
- Earning Date
- FDUS 07-31-2025
- QURE 07-31-2025
- Dividend Yield
- FDUS 10.68%
- QURE N/A
- EPS Growth
- FDUS N/A
- QURE N/A
- EPS
- FDUS 2.33
- QURE N/A
- Revenue
- FDUS $147,999,000.00
- QURE $20,201,000.00
- Revenue This Year
- FDUS $4.94
- QURE N/A
- Revenue Next Year
- FDUS $6.51
- QURE $278.91
- P/E Ratio
- FDUS $9.09
- QURE N/A
- Revenue Growth
- FDUS 9.06
- QURE 6.30
- 52 Week Low
- FDUS $16.70
- QURE $4.45
- 52 Week High
- FDUS $23.55
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- FDUS 69.16
- QURE 50.64
- Support Level
- FDUS $20.68
- QURE $14.03
- Resistance Level
- FDUS $21.07
- QURE $15.16
- Average True Range (ATR)
- FDUS 0.29
- QURE 0.63
- MACD
- FDUS 0.10
- QURE 0.02
- Stochastic Oscillator
- FDUS 99.90
- QURE 67.88
About FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.